222 related articles for article (PubMed ID: 23123064)
1. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide.
Izawa K; Yamanishi Y; Maehara A; Takahashi M; Isobe M; Ito S; Kaitani A; Matsukawa T; Matsuoka T; Nakahara F; Oki T; Kiyonari H; Abe T; Okumura K; Kitamura T; Kitaura J
Immunity; 2012 Nov; 37(5):827-39. PubMed ID: 23123064
[TBL] [Abstract][Full Text] [Related]
2. Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation.
Matsukawa T; Izawa K; Isobe M; Takahashi M; Maehara A; Yamanishi Y; Kaitani A; Okumura K; Teshima T; Kitamura T; Kitaura J
Gut; 2016 May; 65(5):777-87. PubMed ID: 25673319
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation.
Izawa K; Isobe M; Matsukawa T; Ito S; Maehara A; Takahashi M; Yamanishi Y; Kaitani A; Oki T; Okumura K; Kitamura T; Kitaura J
J Allergy Clin Immunol; 2014 Jan; 133(1):270-3.e1-7. PubMed ID: 24035150
[No Abstract] [Full Text] [Related]
4. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells.
Izawa K; Kitaura J; Yamanishi Y; Matsuoka T; Kaitani A; Sugiuchi M; Takahashi M; Maehara A; Enomoto Y; Oki T; Takai T; Kitamura T
J Immunol; 2009 Jul; 183(2):925-36. PubMed ID: 19561101
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a.
Bachelet I; Munitz A; Levi-Schaffer F
J Allergy Clin Immunol; 2006 Jun; 117(6):1314-20. PubMed ID: 16750992
[TBL] [Abstract][Full Text] [Related]
6. Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.
Shiba E; Izawa K; Kaitani A; Isobe M; Maehara A; Uchida K; Maeda K; Nakano N; Ogawa H; Okumura K; Kitamura T; Shimizu T; Kitaura J
J Biol Chem; 2017 Feb; 292(7):2924-2932. PubMed ID: 28073916
[TBL] [Abstract][Full Text] [Related]
7. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
Masuda A; Nakamura A; Maeda T; Sakamoto Y; Takai T
J Exp Med; 2007 Apr; 204(4):907-20. PubMed ID: 17420263
[TBL] [Abstract][Full Text] [Related]
8. [An inhibitory receptor LMIR3/CD300f recognizes ceramide].
Kitaura J; Izawa K; Kitamura T
Seikagaku; 2013 Dec; 85(12):1071-5. PubMed ID: 24505937
[No Abstract] [Full Text] [Related]
9. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
MacNeil AJ; Yang YJ; Lin TJ
J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.
Katz HR
Immunol Rev; 2007 Jun; 217():222-30. PubMed ID: 17498062
[TBL] [Abstract][Full Text] [Related]
11. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4.
Vennekens R; Olausson J; Meissner M; Bloch W; Mathar I; Philipp SE; Schmitz F; Weissgerber P; Nilius B; Flockerzi V; Freichel M
Nat Immunol; 2007 Mar; 8(3):312-20. PubMed ID: 17293867
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone.
Kobayashi M; Nunomura S; Gon Y; Endo D; Kishiro S; Fukunaga M; Kitahata Y; Terui T; Ra C
J Invest Dermatol; 2010 Mar; 130(3):725-31. PubMed ID: 19741711
[TBL] [Abstract][Full Text] [Related]
13. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
Samayawardhena LA; Pallen CJ
J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
[TBL] [Abstract][Full Text] [Related]
14. An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions.
Hitomi K; Tahara-Hanaoka S; Someya S; Fujiki A; Tada H; Sugiyama T; Shibayama S; Shibuya K; Shibuya A
Nat Immunol; 2010 Jul; 11(7):601-7. PubMed ID: 20526344
[TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor modulates acute and late mast cell responses.
Sibilano R; Frossi B; Calvaruso M; Danelli L; Betto E; Dall'Agnese A; Tripodo C; Colombo MP; Pucillo CE; Gri G
J Immunol; 2012 Jul; 189(1):120-7. PubMed ID: 22649193
[TBL] [Abstract][Full Text] [Related]
16. Selective impairment of FcepsilonRI-mediated allergic reaction in Gads-deficient mice.
Yamasaki S; Takase-Utsugi M; Ishikawa E; Sakuma M; Nishida K; Saito T; Kanagawa O
Int Immunol; 2008 Oct; 20(10):1289-97. PubMed ID: 18664516
[TBL] [Abstract][Full Text] [Related]
17. [LEUKOCYTE MONO-IMMUNOGLOBULIN-LIKE RECEPTOR (LMIR3)-MEDIATED INHIBITION OF ALLERGY AND INFLAMMATION].
Izawa K
Arerugi; 2017; 66(1):36-41. PubMed ID: 28216535
[No Abstract] [Full Text] [Related]
18. The Emerging Picture of Mast Cell Activation: The Complex Regulatory Network of High-Affinity Receptor for Immunoglobulin E Signaling.
Suzuki R
Biol Pharm Bull; 2017; 40(11):1828-1832. PubMed ID: 29093329
[TBL] [Abstract][Full Text] [Related]
19. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
20. Positive and negative regulatory mechanisms in high-affinity IgE receptor-mediated mast cell activation.
Roth K; Chen WM; Lin TJ
Arch Immunol Ther Exp (Warsz); 2008; 56(6):385-99. PubMed ID: 19082920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
